Pulmonary embolism in hospitalised patients with COVID-19

Martin Whyte

Philip Kelly

Elisa Gonzalez

Roopen Arya

Lara Roberts

^{Dept of Medicine, King's College NHS Foundation Trust, London, UK}

^{Dept Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK}

^{King's Thrombosis Centre, Department of Haematological Medicine, King's College NHS Foundation Trust, London, UK}

Lara N. Roberts: ten.shn@strebor.aral

^{Corresponding author at: Dept of Haematological Medicine, 4}^{Floor Hambleden Wing, King's College Hospital, London SE5 9RS, UK.}ten.shn@strebor.aral

Received 2020 May 28; Revised 2020 Jun 25; Accepted 2020 Jul 8.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

Background

Coronavirus disease 2019 (COVID-19) is characterised by dyspnoea and abnormal coagulation parameters, including raised D-dimer. Data suggests a high incidence of pulmonary embolism (PE) in ventilated patients with COVID-19.

Objectives

To determine the incidence of PE in hospitalised patients with COVID-19 and the diagnostic yield of Computer Tomography Pulmonary Angiography (CTPA) for PE. We also examined the utility of D-dimer and conventional pre-test probability for diagnosis of PE in COVID-19.

Patients/methods

Retrospective review of single-centre data of all CTPA studies in patients with suspected or confirmed COVID-19 identified from Electronic Patient Records (EPR).

Results

There were 1477 patients admitted with COVID-19 and 214 CTPA scans performed, of which n = 180 (84%) were requested outside of critical care. The diagnostic yield for PE was 37%. The overall proportion of PE in patients with COVID-19 was 5.4%. The proportions with Wells score of ≥4 (‘PE likely’) was 33/134 (25%) without PE vs 20/80 (25%) with PE (P = 0.951). The median National Early Warning-2 (NEWS2) score (illness severity) was 5 (interquartile range [IQR] 3–9) in PE group vs 4 (IQR 2–7) in those without PE (P = 0.133). D-dimer was higher in PE (median 8000 ng/mL; IQR 4665–8000 ng/mL) than non-PE (2060 ng/mL, IQR 1210–4410 ng/mL, P < 0.001). In the ‘low probability’ group, D-dimer was higher (P < 0.001) in those with PE but had a limited role in excluding PE.

Conclusions

Even outside of the critical care environment, PE in hospitalised patients with COVID-19 is common. Of note, approaching half of PE events were diagnosed on hospital admission. More data are needed to identify an optimal diagnostic pathway in patients with COVID-19. Randomised controlled trials of intensified thromboprophylaxis are urgently needed.

Click here to view.^{Supplementary Table 1}

Declaration of competing interest

The authors have no disclosures.

References

1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., Du B., Li L.J., Zeng G., Yuen K.Y., Chen R.C., Tang C.L., Wang T., Chen P.Y., Xiang J., Li S.Y., Wang J.L., Liang Z.J., Peng Y.X., Wei L., Liu Y., Hu Y.H., Peng P., Wang J.M., Liu J.Y., Chen Z., Li G., Zheng Z.J., Qiu S.Q., Luo J., Ye C.J., Zhu S.Y., Zhong N.S., China Medical Treatment Expert Group for C Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2002032.] [
2. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., Xia J., Yu T., Zhang X., Zhang LEpidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/S0140-6736(20)30211-7.] [[Google Scholar]
3. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao BClinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5.] [[Google Scholar]
4. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., Zhao Y., Li Y., Wang X., Peng ZClinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020 doi: 10.1001/jama.2020.1585.] [[Google Scholar]
5. Cui S., Chen S., Li X., Liu S., Wang FPrevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. 2020 doi: 10.1111/jth.14830.] [[Google Scholar]
6. Helms J., Tacquard C., Fo Severac, Leonard-Lorant I., Ml Ohana, Delabranche X., Merdji H., Clere-Jehl R.L., Schenck M., Fagot Gandet F., Fafi-Kremer S., Castelain V., Schneider F., Grunebaum L.L., Angles-Cano E., Sattler L., Mertes P.-M., Meziani F., Group CT High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020 doi: 10.1007/s00134-020-06062-x.] [
7. Klok F.K., Kruip M.J.H.A., van der Meer N.J.M., Arbous M.S., Gommers D.A.M.P.J., Kant K.M., Kaptein F.H.J., van Paassen J., Stals M.A.M., Huisman M.V., Endeman HIncidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb. Res. 2020 doi: 10.1016/j.thromres.2020.04.013. [Epub ahead of print] ] [[Google Scholar]
8. Middeldorp S., Coppens M., van Haaps T.F., Foppen M., Vlaar A.P., MCA Müller, CCS Bouman, LFM Beenen, Kootte R.S., Heijmans J., Smits L.P., Bonta P.I., van Es NIncidence of venous thromboembolism in hospitalized patients with COVID-19. J. Thromb. Haemost. 2020 doi: 10.1111/jth.14888. [n/a] [] [[PubMed][Google Scholar]
9. Lodigiani C., Iapichino G., Carenzo L., Cecconi M., Ferrazzi P., Sebastian T., Kucher N., Studt J.-D., Sacco C., Alexia B., Sandri M.T., Barco SVenous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb. Res. 2020;191:9–14. doi: 10.1016/j.thromres.2020.04.024.] [[Google Scholar]
10. Lippi G., Plebani MLaboratory abnormalities in patients with COVID-2019 infection. Clin. Chem. Lab. Med. 2020 doi: 10.1515/cclm-2020-0198.] [[PubMed][Google Scholar]
11. Lippi G., Favaloro E.JD-dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thromb. Haemost. 2020 doi: 10.1055/s-0040-1709650.] [[Google Scholar]
12. Tang N., Li D., Wang X., Sun ZAbnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:844–847. doi: 10.1111/jth.14768.] [[Google Scholar]
13. Perrier A., Desmarais S., Goehring C., de Moerloose P., Morabia A., Unger P.F., Slosman D., Junod A., Bounameaux HD-dimer testing for suspected pulmonary embolism in outpatients. Am. J. Respir. Crit. Care Med. 1997;156:492–496. doi: 10.1164/ajrccm.156.2.9702032.] [[PubMed][Google Scholar]
14. Geersing G.J., Erkens P.M., Lucassen W.A., Buller H.R., Cate H.T., Hoes A.W., Moons K.G., Prins M.H., Oudega R., van Weert H.C., Stoffers H.ESafe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study. BMJ. 2012;345 doi: 10.1136/bmj.e6564.] [[Google Scholar]
15. van Es N., Kraaijpoel N., Klok F.A., Huisman M.V., Den Exter P.L., Mos I.C., Galipienzo J., Buller H.R., Bossuyt P.MThe original and simplified Wells rules and age-adjusted D-dimer testing to rule out pulmonary embolism: an individual patient data meta-analysis. J. Thromb. Haemost. 2017;15:678–684. doi: 10.1111/jth.13630.] [[PubMed][Google Scholar]
16. Geissenberger F., Schwarz F., Probst M., Haberl S., Gruetzner S., Kroencke T., von Scheidt W., Berghaus T.MD-dimer predicts disease severity but not long-term prognosis in acute pulmonary embolism. Clin. Appl. Thromb. Hemost. 2019;25 doi: 10.1177/1076029619863495. [1076029619863495] ] [[Google Scholar]
17. Ghanima W., Abdelnoor M., Holmen L.O., Nielssen B.E., Ross S., Sandset P.MD-dimer level is associated with the extent of pulmonary embolism. Thromb. Res. 2007;120:281–288. doi: 10.1016/j.thromres.2006.08.006.] [[PubMed][Google Scholar]
18. Ji Y., Sun B., Juggessur-Mungur K.S., Li Z., Zhang ZCorrelation of D-dimer level with the radiological severity indexes of pulmonary embolism on computed tomography pulmonary angiography. Chin. Med. J. 2014;127:2025–2029.[PubMed][Google Scholar]
19. Public Health England . 2020. Coronavirus-19 (COVID-19) in the UK. [PubMed]
20. Royal College of Physicians National Early Warning Score (NEWS) 2: Standardising the Assessment of Acute-illness Severity in the NHS2017. Retrieved from. (Accessed 5^{April 2020)}[PubMed]
21. Sharma S., Kelly P., Whyte M.BInflation of Wells score to obtain computed tomography pulmonary angiogram: an example of cognitive dissonance? Clin. Med. (Lond.) 2017;17 doi: 10.7861/clinmedicine.17-3-s5.] [[Google Scholar]
22. Wells P.S., Ginsberg J.S., Anderson D.R., Kearon C., Gent M., Turpie A.G., Bormanis J., Weitz J., Chamberlain M., Bowie D., Barnes D., Hirsh JUse of a clinical model for safe management of patients with suspected pulmonary embolism. Ann. Intern. Med. 1998;129:997–1005. doi: 10.7326/0003-4819-129-12-199812150-00002.] [[PubMed][Google Scholar]
23. Is My Study Research? HRA Decision Tool. [5^{April 2020]}[PubMed]
24. Chen Z., Deblois S., Toporowicz K., Boldeanu I., Francoeur M.O., Sadouni M., Lepanto L., Chartrand-Lefebvre CYield of CT pulmonary angiography in the diagnosis of acute pulmonary embolism: short report. BMC Res. Notes. 2019;12:41. doi: 10.1186/s13104-019-4076-8.] [[Google Scholar]
25. Costa A.F., Basseri H., Sheikh A., Stiell I., Dennie CThe yield of CT pulmonary angiograms to exclude acute pulmonary embolism. Emerg. Radiol. 2014;21:133–141. doi: 10.1007/s10140-013-1169-x.] [[PubMed][Google Scholar]
26. Costantino M.M., Randall G., Gosselin M., Brandt M., Spinning K., Vegas C.DCT angiography in the evaluation of acute pulmonary embolus. AJR Am. J. Roentgenol. 2008;191:471–474. doi: 10.2214/AJR.07.2552.] [[PubMed][Google Scholar]
27. Desborough M.J.R., Doyle A.J., Griffiths A., Retter A., Breen K.A., Hunt B.JImage-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom. Thromb. Res. 2020;193:1–4. [S0049-3848(20)30229-2 [pii]] [Google Scholar]
28. van Dam L.F., Kroft L.J.M., van der Wal L.I., Cannegieter S.C., Eikenboom J., de Jonge E., Huisman M.V., Klok F.AClinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: a different phenotype of thrombotic disease? Thromb. Res. 2020;193:86–89. doi: 10.1016/j.thromres.2020.06.010. [10.1016/j.thromres.2020.05.049 [doi] S0049-3848(20)30252-8 [pii]] ] [[Google Scholar]